George Kemble
Executive Chairman at Sagimet Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Sagimet Biosciences Inc., 3 years.
Sagimet Biosciences Inc.
Director · Executive Chairman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 23, 2024 | Sagimet Biosciences Inc. | Open-market sale | −23,625 | $3.17 | $74,891 |
| Jul 19, 2024 | Sagimet Biosciences Inc. | Open-market sale | −14,062 | $3.10 | $43,592 |
| Nov 17, 2023 | Sagimet Biosciences Inc. | Grant or award | +150,750 | — | — |
| Sep 7, 2023 | Sagimet Biosciences Inc. | Option exercise | +5,630 | $0.79 | $4,448 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.